Company: XOMAP
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001558370-25-007494
Chunk: 5

Company: XOMA Royalty Corp
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 1C
Chunk 5
---
Preferred stock dividend accrual ​​ 1,368​​ 1,368Current portion of long-term debt​​ 13,697​​ 11,394Total current liabilities​  20,434​  24,374Unearned revenue recognized under units-of-revenue method – long-term​  4,084​  4,410Exarafenib milestone contingent consideration (Note 4)​​ 3,307​​ 3,214Long-term operating lease liabilities ​​ 362​​ 483Long-term debt​​ 99,934​​ 106,875Total liabilities​  128,121​  139,356​​​​​​​Commitments and Contingencies (Note 10)​​​​​​​​​​​​​Stockholders’ equity:​​​​​​Preferred Stock, $0.05 par value, 1,000,000 shares authorized:​​​​​​8.625% Series A cumulative, perpetual preferred stock, 984,000 shares issued and outstanding as of March 31, 2025 and December 31, 2024​​ 49​​ 498.375% Series B cumulative, perpetual preferred stock, 1,600 shares issued and outstanding as of March 31, 2025 and December 31, 2024​​ —​  —Convertible preferred stock, 5,003 shares issued and outstanding as of March 31, 2025 and December 31, 2024​  —​  —Common stock, $0.0075 par value, 277,333,332 shares authorized, 11,952,889 and 11,952,377 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively​  90​  90Additional paid-in capital​  1,319,607​  1,318,766Accumulated other comprehensive income​​ 118​​ 73Accumulated deficit​  (1,235,235)​  (1,237,057)Total stockholders’ equity​  84,629​  81,921Total liabilities and stockholders’ equity​$ 212,750​$ 221,277

​

The accompanying notes are an integral part of these condensed consolidated financial statements.